SUN PHARMACEUTICAL IND L vs SUPRIYA LIFESCIENCE LTD

A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and SUPRIYA LIFESCIENCE LTD (SUPRIYA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUPRIYA LIFESCIENCE LTD leads SUNPHARMA vs SUPRIYA on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

40.40
P/E ratio
35.49
5.57
P/B ratio
5.88
0.83%
Dividend yield
0.11%
₹47.84
EPS
₹23.35

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.00%
Return on equity
18.86%
21.00%
Return on capital
27.00%
30.00%
EBITDA margin
37.00%
19.69%
Net margin
27.01%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
21.55%
10.57%
Profit CAGR (3Y)
32.45%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.64L Cr
Market cap
₹6,672 Cr
₹58,462 Cr
Revenue
₹696 Cr
₹11,509 Cr
Net profit
₹188 Cr
0.06
Debt / equity
0.00
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
SUPRIYA LIFESCIENCE LTD
  • + ["Company is almost debt free.", "Company is expected to give good quarter"]
  • ["Debtor days have increased from 79.6 to 96.8 days."]
SUN PHARMACEUTICAL IND L full analysis SUPRIYA LIFESCIENCE LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

SUN PHARMACEUTICAL IND L vs SUPRIYA LIFESCIENCE LTD: Share Price, Valuation & Which to Buy | DocStoX